Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Number of holders
-
1,481
-
Total 13F shares, excl. options
-
233,778,905
-
Shares change
-
-847,545
-
Total reported value, excl. options
-
$97,614,728,920
-
Value change
-
-$351,588,308
-
Put/Call ratio
-
111%
-
Number of buys
-
760
-
Number of sells
-
612
-
Price
-
$418.01
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2024
As of 31 Mar 2024 VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) had 1,675 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 233,778,905 shares of stock of the company.
Largest 10 holders included Capital World Investors, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, ALLIANCEBERNSTEIN L.P., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Capital Research Global Investors, and JENNISON ASSOCIATES LLC.
This table shows 1,675 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.